Free Trial

AtriCure (ATRC) News Today

AtriCure logo
$32.71 -0.10 (-0.30%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$32.71 0.00 (0.00%)
As of 05/23/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ATRC Latest News

AtriCure, Inc. stock logo
Two Sigma Advisers LP Has $19.54 Million Stock Position in AtriCure, Inc. (NASDAQ:ATRC)
Two Sigma Advisers LP lowered its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 3.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 639,400 shares of the medical device company's stock af
AtriCure, Inc. stock logo
Nuveen Asset Management LLC Sells 149,584 Shares of AtriCure, Inc. (NASDAQ:ATRC)
Nuveen Asset Management LLC trimmed its stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 12.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,037,348 shares of the medical device company's stock afte
AtriCure, Inc. stock logo
Focus Partners Wealth Acquires Shares of 16,306 AtriCure, Inc. (NASDAQ:ATRC)
Focus Partners Wealth acquired a new stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 16,306 shares of the medical device company's stock, valued at
AtriCure, Inc. stock logo
D. E. Shaw & Co. Inc. Sells 49,834 Shares of AtriCure, Inc. (NASDAQ:ATRC)
D. E. Shaw & Co. Inc. reduced its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 42.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 67,462 shares of the medical device company's stock after sellin
AtriCure, Inc. stock logo
Sherbrooke Park Advisers LLC Invests $330,000 in AtriCure, Inc. (NASDAQ:ATRC)
Sherbrooke Park Advisers LLC purchased a new position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 10,792 shares of the medical device company's stoc
AtriCure, Inc. stock logo
BNP Paribas Financial Markets Purchases 84,776 Shares of AtriCure, Inc. (NASDAQ:ATRC)
BNP Paribas Financial Markets lifted its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 676.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 97,310 shares of the medical device company's
AtriCure, Inc. stock logo
Northern Trust Corp Has $14.78 Million Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC)
Northern Trust Corp lifted its stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 11.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 483,607 shares of the medical device company's stock after acqu
AtriCure, Inc. stock logo
LMR Partners LLP Invests $499,000 in AtriCure, Inc. (NASDAQ:ATRC)
LMR Partners LLP acquired a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 16,313 shares of the medical device company's stock, valued a
AtriCure, Inc. stock logo
Graham Capital Management L.P. Purchases Shares of 21,249 AtriCure, Inc. (NASDAQ:ATRC)
Graham Capital Management L.P. purchased a new position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm purchased 21,249 shares of the medical device company's stock, valued at approximately $649,000. Several
AtriCure, Inc. stock logo
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Recommendation of "Buy" from Brokerages
Shares of AtriCure, Inc. (NASDAQ:ATRC - Get Free Report) have been assigned a consensus recommendation of "Buy" from the nine brokerages that are currently covering the company, MarketBeat reports. Nine research analysts have rated the stock with a buy rating. The average 12 month price objective
AtriCure, Inc. stock logo
Balyasny Asset Management L.P. Decreases Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC)
Balyasny Asset Management L.P. decreased its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 50.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 76,190 shares of the medical device compa
AtriCure, Inc. stock logo
Centiva Capital LP Takes Position in AtriCure, Inc. (NASDAQ:ATRC)
Centiva Capital LP purchased a new position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 16,687 shares of the medical device company's stock, valued at app
AtriCure, Inc. stock logo
Algert Global LLC Has $2.94 Million Stock Position in AtriCure, Inc. (NASDAQ:ATRC)
Algert Global LLC raised its stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 10.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 96,199 shares of the medical device company's stock after acquiring an
AtriCure, Inc. stock logo
Dimensional Fund Advisors LP Purchases 136,015 Shares of AtriCure, Inc. (NASDAQ:ATRC)
Dimensional Fund Advisors LP lifted its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 24.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 700,212 shares of the medical device company's
AtriCure, Inc. stock logo
AtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Divisadero Street Capital Management LP
Divisadero Street Capital Management LP reduced its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 83.6% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 212,982 shares of the medical device company's
AtriCure, Inc. stock logo
Aquatic Capital Management LLC Sells 15,898 Shares of AtriCure, Inc. (NASDAQ:ATRC)
Aquatic Capital Management LLC cut its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 40.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 23,102 shares of the medical device company's stock after selling 15,898 shares du
AtriCure, Inc. stock logo
PDT Partners LLC Acquires 15,626 Shares of AtriCure, Inc. (NASDAQ:ATRC)
PDT Partners LLC raised its holdings in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 65.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 39,327 shares of the medical device company's stock after buy
AtriCure, Inc. stock logo
AtriCure, Inc. (NASDAQ:ATRC) Stake Trimmed by Barclays PLC
Barclays PLC lessened its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 33.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 86,541 shares of the medical device company's stock after selling 4
AtriCure, Inc. stock logo
UBS Group Issues Pessimistic Forecast for AtriCure (NASDAQ:ATRC) Stock Price
UBS Group dropped their price objective on AtriCure from $60.00 to $58.00 and set a "buy" rating on the stock in a research report on Wednesday.
AtriCure, Inc. stock logo
AtriCure (NASDAQ:ATRC) Given Market Outperform Rating at JMP Securities
JMP Securities reaffirmed a "market outperform" rating and issued a $60.00 price target on shares of AtriCure in a report on Wednesday.
AtriCure, Inc. stock logo
AtriCure (NASDAQ:ATRC) Shares Gap Down on Analyst Downgrade
AtriCure (NASDAQ:ATRC) Shares Gap Down on Analyst Downgrade
AtriCure, Inc. stock logo
AtriCure (NASDAQ:ATRC) Price Target Lowered to $44.00 at Needham & Company LLC
Needham & Company LLC reduced their price objective on shares of AtriCure from $51.00 to $44.00 and set a "buy" rating for the company in a research report on Wednesday.
AtriCure, Inc. stock logo
Emerald Mutual Fund Advisers Trust Sells 230,096 Shares of AtriCure, Inc. (NASDAQ:ATRC)
Emerald Mutual Fund Advisers Trust reduced its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 92.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 19,408 shares of the medical devic
AtriCure, Inc. stock logo
Susquehanna Fundamental Investments LLC Invests $3.18 Million in AtriCure, Inc. (NASDAQ:ATRC)
Susquehanna Fundamental Investments LLC acquired a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 104,094 shares of the medical device comp
AtriCure, Inc. stock logo
Nebula Research & Development LLC Sells 9,703 Shares of AtriCure, Inc. (NASDAQ:ATRC)
Nebula Research & Development LLC decreased its holdings in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 35.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 17,363 shares of the medical device comp
AtriCure, Inc. stock logo
AtriCure (NASDAQ:ATRC) Stock Price Up 4.9% Following Earnings Beat
AtriCure (NASDAQ:ATRC) Trading 4.9% Higher After Earnings Beat
AtriCure, Inc. stock logo
AtriCure (NASDAQ:ATRC) Issues Quarterly Earnings Results
AtriCure (NASDAQ:ATRC - Get Free Report) announced its quarterly earnings data on Tuesday. The medical device company reported ($0.14) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.25) by $0.11. AtriCure had a negative net margin of 9.61% and a negative return on equity of 6.80%.
AtriCure, Inc. stock logo
Adage Capital Partners GP L.L.C. Makes New $9.17 Million Investment in AtriCure, Inc. (NASDAQ:ATRC)
Adage Capital Partners GP L.L.C. bought a new position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 300,000 shares of the medical device company's stock, val
AtriCure, Inc. stock logo
AtriCure, Inc. (NASDAQ:ATRC) is First Light Asset Management LLC's 4th Largest Position
First Light Asset Management LLC raised its holdings in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 5.6% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,969,221 shares of the medical device company's stock after acquiring
AtriCure Earnings Preview
AtriCure, Inc. stock logo
Raymond James Financial Inc. Makes New $3.72 Million Investment in AtriCure, Inc. (NASDAQ:ATRC)
Raymond James Financial Inc. purchased a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 121,591 shares of the medical device compa
AtriCure, Inc. stock logo
Wells Fargo & Company MN Sells 37,874 Shares of AtriCure, Inc. (NASDAQ:ATRC)
Wells Fargo & Company MN lessened its stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 39.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 57,407 shares of the medical device company's s
AtriCure, Inc. stock logo
Oberweis Asset Management Inc. Buys New Holdings in AtriCure, Inc. (NASDAQ:ATRC)
Oberweis Asset Management Inc. acquired a new stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 151,500 shares of the medical device c
AtriCure, Inc. stock logo
25,164 Shares in AtriCure, Inc. (NASDAQ:ATRC) Bought by Dark Forest Capital Management LP
Dark Forest Capital Management LP purchased a new stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 25,164 shares of the medical device company's
AtriCure, Inc. stock logo
Canada Pension Plan Investment Board Grows Stake in AtriCure, Inc. (NASDAQ:ATRC)
Canada Pension Plan Investment Board raised its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 756.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 35,100 shares of the medic
AtriCure, Inc. stock logo
Hood River Capital Management LLC Raises Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC)
Hood River Capital Management LLC raised its position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 3.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,923,731 shares of the medical dev
AtriCure, Inc. stock logo
Natixis Makes New $1.85 Million Investment in AtriCure, Inc. (NASDAQ:ATRC)
Natixis acquired a new stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 60,500 shares of the medical device company's stock, valued at approximately $1,849,000. Natixis owned approximately 0.12
AtriCure, Inc. stock logo
AtriCure (ATRC) Expected to Announce Earnings on Tuesday
AtriCure (NASDAQ:ATRC) will be releasing its Q1 2025 earnings after the market closes on Tuesday, April 29. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-4-29-atricure-inc-stock/)
AtriCure, Inc. stock logo
Jump Financial LLC Sells 54,296 Shares of AtriCure, Inc. (NASDAQ:ATRC)
Jump Financial LLC decreased its holdings in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 65.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 28,878 shares of the medical device company's s
Get AtriCure News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter.

ATRC Media Mentions By Week

ATRC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ATRC
News Sentiment

1.38

0.75

Average
Medical
News Sentiment

ATRC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ATRC Articles
This Week

8

5

ATRC Articles
Average Week

Get AtriCure News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ATRC) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners